ABVC
ABVC BIOPHARMA, INC.
Company overview
- Market capitalization
- —
- Employees
- 16
- Latest publication
- 2026-09-29
About ABVC BIOPHARMA, INC.
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients. It is also developing ABV-1701 Vitargus, which is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer; ABV-2001, an intraocular irrigation solution; ABV-2002, a corneal Storage Solution; and ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer. The company has a co-development agreement with Rgene Corporation and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | -795,950USD | 795,950USD | 0USD | 1,966USD | 1,966USD | 389,276USD | 117,142USD |
| Cost Of Revenue | 92,156USD | 214,043USD | 0USD | 80,832USD | 113,948USD | 0USD | 296USD | 190USD |
| Gross Profit | -92,156USD | -795,950USD | 795,950USD | -80,832USD | 1,966USD | 1,966USD | 388,980USD | 116,952USD |
| Research Development | 33,100USD | 29,058USD | 29,890USD | 33,276USD | 28,861USD | 31,980USD | 37,825USD | 40,401USD |
| Selling General Administrative | 1,539,372USD | 2,169,853USD | 1,934,470USD | 2,261,707USD | 664,144USD | 304,144USD | 301,208USD | 944,180USD |
| Total Operating Expenses | 1,572,472USD | 2,198,911USD | 1,964,360USD | 2,294,983USD | 693,005USD | 336,124USD | 339,033USD | 977,059USD |
| Operating Income | -1,572,472USD | -2,994,861USD | -1,964,360USD | -2,294,983USD | -693,005USD | -334,158USD | 49,947USD | -860,107USD |
| Interest Income | 3,765USD | 81,606USD | 47,287USD | 19,139USD | 19,071USD | 11,907USD | 44,261USD | 27,141USD |
| Interest Expense | 49,377USD | 32,551USD | 30,959USD | 129,413USD | 222,967USD | 338,349USD | 219,533USD | 207,079USD |
| Net Interest Income | -45,612USD | 49,055USD | 16,328USD | -110,274USD | -203,896USD | 350,256USD | -175,272USD | -232,891USD |
| Income Before Tax | -1,689,937USD | -3,812,413USD | -2,082,946USD | -2,309,206USD | -944,190USD | 128,943USD | -133,917USD | -1,158,306USD |
| Income Tax Expense | -1,560,242USD | 527USD | 527USD | 23,627USD | — | — | 355USD | -110,894USD |
| Tax Provision | 0USD | 0USD | 527USD | 23,627USD | 0USD | 0USD | 355USD | -110,894USD |
| Net Income | -1,560,242USD | -3,562,944USD | -2,042,463USD | -2,257,022USD | -842,075USD | 229,304USD | -186,561USD | -942,336USD |
| Net Income From Continuing Ops | -1,689,937USD | -3,812,413USD | -1,287,523USD | -2,332,833USD | -944,190USD | 128,943USD | -134,272USD | -1,272,689USD |
| Ebit | -1,640,560USD | -3,779,862USD | -2,051,987USD | -2,179,793USD | -721,223USD | — | 280,884USD | -951,227USD |
| Ebitda | -1,548,404USD | -3,565,819USD | -1,955,976USD | -2,098,961USD | -607,275USD | — | 85,616USD | -836,900USD |
| Depreciation And Amortization | 92,156USD | 214,043USD | 96,011USD | 80,832USD | 113,948USD | — | -195,268USD | 114,327USD |
| Reconciled Depreciation | 92,156USD | 214,043USD | 96,011USD | 80,832USD | 113,948USD | 179,316USD | 7,014USD | 13,305USD |
| Total Other Income Expense Net | -117,465USD | -817,552USD | -118,586USD | -14,223USD | -251,185USD | 112,845USD | -183,864USD | -298,199USD |
| Minority Interest | 129,695USD | 249,469USD | 41,010USD | 75,811USD | 102,115USD | 100,361USD | -52,289USD | 260,044USD |
| Selling And Marketing Expenses | — | — | — | — | 1,286USD | — | — | 13,305USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 795,950USD | 509,589USD | 152,430USD | 969,783USD | 355,797USD | 483,045USD | 701,719USD | 6,956USD |
| Cost Of Revenue | 504,834USD | 763USD | 302,037USD | 286,415USD | 5,086USD | 18,716USD | 20,137USD | 228,890USD |
| Gross Profit | 795,950USD | 508,826USD | -149,607USD | 683,368USD | 350,711USD | 464,329USD | 681,582USD | -221,934USD |
| Research Development | 121,085USD | 179,272USD | 1,062,916USD | 2,693,457USD | 1,003,805USD | 549,658USD | 1,048,553USD | 988,721USD |
| Selling General Administrative | 7,030,174USD | 5,034,796USD | 5,554,211USD | 13,104,323USD | 11,052,874USD | 8,420,447USD | 3,091,807USD | 723,948USD |
| Total Operating Expenses | 7,151,259USD | 5,214,068USD | 6,617,127USD | 15,797,780USD | 12,056,679USD | 8,970,105USD | 4,140,360USD | 2,562,629USD |
| Operating Income | -7,151,259USD | -4,705,242USD | -6,766,734USD | -15,114,412USD | -11,705,968USD | -8,505,776USD | -3,458,778USD | -2,784,563USD |
| Interest Income | 167,103USD | 87,358USD | 185,481USD | 187,817USD | 43,196USD | 71,045USD | 23,344USD | 93USD |
| Interest Expense | 415,890USD | 825,899USD | 1,313,671USD | 293,968USD | 227,210USD | 405,032USD | 482,014USD | 462,751USD |
| Net Interest Income | -248,787USD | -738,541USD | -2,307,859USD | -106,151USD | -184,014USD | -333,987USD | -458,670USD | -155,837USD |
| Income Before Tax | -8,352,805USD | -5,369,576USD | -8,024,838USD | -15,514,596USD | -11,210,827USD | -10,813,936USD | -4,010,281USD | -6,429,627USD |
| Income Tax Expense | 24,154USD | -110,539USD | 256,006USD | 797,778USD | 825,024USD | -220,352USD | -77,041USD | -365,097USD |
| Tax Provision | 24,154USD | -110,539USD | 256,006USD | 797,778USD | 825,024USD | -220,352USD | -77,041USD | 1,850USD |
| Net Income | -7,908,554USD | -4,902,878USD | -7,788,050USD | -16,423,239USD | -12,838,813USD | -9,791,164USD | -3,641,776USD | -5,575,379USD |
| Net Income From Continuing Ops | -8,376,959USD | -5,259,037USD | -10,910,288USD | -16,312,374USD | -12,035,851USD | -10,593,584USD | -3,933,240USD | -4,101,303USD |
| Ebit | -7,936,915USD | -4,543,677USD | -6,711,167USD | -15,220,628USD | -10,983,617USD | -10,408,904USD | -3,528,267USD | -5,966,881USD |
| Ebitda | -7,432,081USD | -4,342,756USD | -6,330,777USD | -15,196,829USD | -10,971,624USD | -10,371,762USD | -3,473,181USD | -5,923,271USD |
| Depreciation And Amortization | 504,834USD | 200,921USD | 380,390USD | 23,799USD | 11,993USD | 37,142USD | 55,086USD | 43,610USD |
| Reconciled Depreciation | 504,834USD | 200,921USD | 28,531USD | 23,799USD | 11,993USD | 37,142USD | 55,086USD | — |
| Total Other Income Expense Net | -1,201,546USD | -664,334USD | -1,258,104USD | -400,184USD | 495,141USD | -2,308,160USD | -551,503USD | -3,645,064USD |
| Minority Interest | 468,405USD | 356,159USD | 394,632USD | -110,865USD | -802,962USD | -776,273USD | 26,147USD | 317,610USD |
| Selling And Marketing Expenses | — | — | 28,531USD | — | — | — | — | 695,148USD |
| Net Income Applicable To Common Shares | — | — | — | -16,423,239USD | -12,838,813USD | -9,791,164USD | -3,641,776USD | -5,575,379USD |
| Discontinued Operations | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 19,400,715USD | 19,732,528USD | 21,062,203USD | 21,176,299USD | 16,241,060USD | 14,875,699USD | 7,539,907USD | 14,462,845USD |
| Cash And Equivalents | 31,944USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 94,364USD | 202,509USD | 745,834USD | 257,243USD | 1,141,537USD | 824,620USD | — | 840,682USD |
| Short Term Investments | 62,420USD | 62,185USD | 64,354USD | 65,175USD | 65,211USD | 65,052USD | 64,736USD | 70,809USD |
| Long Term Investments | 2,489,697USD | 1,845,770USD | 1,878,465USD | 2,745,194USD | 2,837,922USD | 2,760,062USD | 2,258,754USD | 2,333,904USD |
| Total Current Assets | 411,729USD | 648,848USD | 2,501,343USD | 4,072,569USD | 2,770,401USD | 1,469,561USD | 2,179,815USD | 2,148,327USD |
| Other Current Assets | 151,559USD | 446,339USD | 1,755,509USD | 3,803,866USD | 194,999USD | 96,362USD | 96,213USD | 91,291USD |
| Other Non Current Assets | 106,682USD | — | — | — | — | — | — | — |
| Total Liabilities | 7,131,155USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 5,694,505USD | 5,393,128USD | 6,163,976USD | 6,507,520USD | 6,532,514USD | 6,730,739USD | 6,557,461USD | 6,315,642USD |
| Total Stockholder Equity | 10,287,183USD | 10,772,533USD | 11,111,861USD | 12,057,619USD | 7,013,635USD | 5,404,386USD | 1,226,140USD | 8,358,466USD |
| Total Equity Including Noncontrolling Interest | 12,269,560USD | — | — | — | — | — | — | — |
| Deferred Revenue | 12,600USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 14,575,865USD | 14,649,890USD | 14,748,687USD | 12,424,777USD | 8,674,691USD | 8,702,206USD | 1,151,475USD | 8,439,137USD |
| Short Term Debt | 358,107USD | 1,219,999USD | 1,872,079USD | 1,227,229USD | 2,136,914USD | 2,822,805USD | — | 2,603,215USD |
| Common Stock | 26,220USD | 25,767USD | 25,053USD | 24,190USD | 19,533USD | 15,378USD | — | 12,712USD |
| Retained Earnings | -79,155,537USD | -78,418,603USD | -76,858,361USD | -73,295,417USD | -72,048,904USD | -69,791,882USD | -68,949,807USD | -70,552,277USD |
| Accumulated Other Comprehensive Income | 498,193USD | 499,650USD | 487,602USD | 487,048USD | 1,574,120USD | 475,212USD | — | 492,322USD |
| Total Liab | — | 6,904,071USD | 7,764,723USD | 6,683,592USD | 6,751,327USD | 6,919,404USD | 6,815,948USD | 6,483,523USD |
| Other Current Liab | — | 4,161,353USD | 4,267,969USD | 5,274,121USD | 4,314,485USD | 3,826,819USD | 430,107USD | 3,632,927USD |
| Capital Stock | — | 25,767USD | 25,053USD | 24,190USD | 19,533USD | 15,378USD | 13,868USD | 12,712USD |
| Cash | — | 140,324USD | 681,480USD | 192,068USD | 1,076,326USD | 759,568USD | 248,382USD | 769,873USD |
| Net Debt | — | 2,590,618USD | 2,791,346USD | 1,199,233USD | 1,237,721USD | 2,230,222USD | 1,541,916USD | 1,975,543USD |
| Short Long Term Debt | — | 887,747USD | 1,554,522USD | 1,027,894USD | 1,126,146USD | 1,636,946USD | 1,790,298USD | 1,818,487USD |
| Short Long Term Debt Total | — | 2,730,942USD | 3,472,826USD | 1,391,301USD | 2,314,047USD | 2,989,790USD | — | 2,745,416USD |
| Property Plant Equipment Gross | — | 18,030,709USD | 18,128,784USD | 15,809,190USD | 12,066,412USD | 12,738,824USD | 4,493,214USD | 11,783,889USD |
| Common Stock Shares Outstanding | — | 25,448,516shares | 23,256,590shares | 23,256,590shares | 17,386,536shares | 14,968,232shares | 13,137,843shares | 12,405,261shares |
| Non Current Assets Total | — | 19,083,680USD | 18,560,860USD | 17,103,730USD | 13,470,659USD | 13,406,137USD | 5,360,092USD | 12,314,518USD |
| Non Current Liabilities Total | — | 1,510,943USD | 1,600,747USD | 176,072USD | 218,812USD | 188,665USD | 258,487USD | 167,880USD |
| Non Currrent Assets Other | — | 2,588,020USD | 1,933,708USD | 1,933,759USD | 1,958,046USD | 1,943,869USD | 133,121USD | 1,417,326USD |
| Net Working Capital | — | -4,744,280USD | -3,662,633USD | -2,434,951USD | -3,762,113USD | -5,211,178USD | -4,377,646USD | -4,167,315USD |
| Unclassified Non Current Liabilities | — | 1,510,943USD | 1,600,747USD | — | — | — | — | — |
| Unclassified Equity | — | 88,639,952USD | 87,432,514USD | 84,817,608USD | 77,449,353USD | 74,690,300USD | 70,162,079USD | 78,392,997USD |
| Unclassified Current Liabilities | — | — | -1,530,594USD | -1,021,724USD | -1,126,146USD | -1,636,946USD | 4,337,056USD | -1,818,487USD |
| Inventory | — | — | — | 11,460USD | 11,460USD | 11,460USD | — | -101,754USD |
| Non Current Liabilities Other | — | — | — | 12,000USD | 41,680USD | 71,680USD | 21,680USD | 25,680USD |
| Current Deferred Revenue | — | — | — | — | 81,115USD | 81,115USD | — | 79,500USD |
| Net Receivables | — | — | — | — | 1,422,405USD | 537,119USD | 0USD | 1,216,354USD |
| Unclassified Current Assets | — | — | — | — | — | — | 1,770,484USD | — |
| Unclassified Non Current Assets | — | — | — | — | — | — | 1,816,742USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 21,062,203USD | 7,539,907USD | 7,784,499USD | 10,934,014USD | 13,698,033USD | 14,767,065USD | 6,927,811USD | 96,273USD |
| Other Current Assets | 1,755,509USD | 96,213USD | 101,051USD | 150,235USD | 1,265,021USD | 172,193USD | 570,377USD | 40,272USD |
| Total Liab | 7,764,723USD | 6,815,948USD | 6,531,026USD | 6,343,435USD | 4,827,691USD | 8,944,638USD | 7,052,628USD | 5,845,691USD |
| Total Stockholder Equity | 11,111,861USD | 1,226,140USD | 1,554,110USD | 4,453,025USD | 8,843,653USD | 6,598,700USD | -150,964USD | -5,749,418USD |
| Other Current Liab | 4,267,969USD | 3,509,422USD | 3,548,352USD | 2,909,587USD | 1,477,453USD | 2,130,924USD | 2,433,262USD | 5,003,585USD |
| Common Stock | 25,053USD | 13,868USD | 7,940USD | 3,286USD | 28,926USD | 24,420USD | 19,478USD | 213,927USD |
| Capital Stock | 25,053USD | 13,868USD | 7,940USD | 32,857USD | 28,926USD | 24,420USD | 19,478USD | 213,927USD |
| Retained Earnings | -76,858,361USD | -68,949,807USD | -64,046,929USD | -54,904,439USD | -38,481,200USD | -25,642,387USD | -15,851,223USD | -19,877,901USD |
| Cash | 681,480USD | 863,815USD | 716,780USD | 1,391,728USD | 5,828,548USD | 5,001,371USD | 144,295USD | 40,044USD |
| Cash And Short Term Investments | 745,834USD | 928,551USD | 796,092USD | 1,467,525USD | 5,936,695USD | 5,001,371USD | 144,295USD | 40,044USD |
| Total Current Assets | 2,501,343USD | 2,179,815USD | 1,656,709USD | 2,987,247USD | 7,653,782USD | 6,172,966USD | 878,238USD | 96,273USD |
| Total Current Liabilities | 6,163,976USD | 6,557,461USD | 6,101,889USD | 5,543,628USD | 3,692,312USD | 4,844,391USD | 6,814,193USD | 5,568,224USD |
| Net Debt | 2,791,346USD | 2,339,916USD | 2,051,768USD | 2,023,155USD | -2,488,890USD | 1,770,019USD | 4,435,111USD | 759,956USD |
| Short Term Debt | 1,872,079USD | 2,966,924USD | 2,361,091USD | 2,623,056USD | 2,214,859USD | 2,690,423USD | 4,343,851USD | 550,000USD |
| Short Long Term Debt | 1,554,522USD | 1,790,298USD | 1,468,706USD | 1,893,750USD | 1,826,881USD | 2,085,800USD | 4,039,603USD | 550,000USD |
| Short Long Term Debt Total | 3,472,826USD | 3,203,731USD | 2,768,548USD | 3,414,883USD | 3,339,658USD | 6,771,390USD | 4,579,406USD | 800,000USD |
| Long Term Investments | 1,878,465USD | 2,258,754USD | 2,527,740USD | 842,070USD | 932,755USD | 1,190,727USD | 3,364,619USD | 0USD |
| Short Term Investments | 64,354USD | 64,736USD | 79,312USD | 75,797USD | 108,147USD | 1,190,727USD | 3,364,619USD | 0USD |
| Property Plant Equipment Net | 14,748,687USD | 1,151,475USD | 1,378,561USD | 1,735,119USD | 1,997,780USD | 2,287,581USD | 1,045,375USD | 510,066USD |
| Property Plant Equipment Gross | 18,128,784USD | 4,493,214USD | 12,113,602USD | 1,735,119USD | 1,997,780USD | 2,287,581USD | 1,045,375USD | — |
| Accumulated Other Comprehensive Income | 487,602USD | 476,705USD | 516,387USD | 517,128USD | -1,717,740USD | 564,860USD | 663,753USD | 1,000,000USD |
| Common Stock Shares Outstanding | 23,256,590shares | 11,673,980shares | 4,335,650shares | 3,166,466shares | 2,505,352shares | 1,971,555shares | 1,749,854shares | 1,188,000shares |
| Non Current Assets Total | 18,560,860USD | 5,360,092USD | 6,127,790USD | 7,946,766USD | 6,044,251USD | 8,594,099USD | 6,049,573USD | 5,373,648USD |
| Non Current Liabilities Total | 1,600,747USD | 258,486USD | 429,136USD | 799,807USD | 1,135,379USD | 4,100,246USD | 238,435USD | 277,467USD |
| Non Currrent Assets Other | 1,933,708USD | 1,949,863USD | 2,107,973USD | 3,032,550USD | 3,113,716USD | 164,834USD | 179,546USD | 27,418USD |
| Net Working Capital | -3,662,633USD | -4,377,646USD | -4,275,781USD | -2,832,282USD | 5,932,808USD | 1,328,575USD | -5,935,955USD | -5,471,951USD |
| Unclassified Current Liabilities | -1,530,594USD | -1,790,298USD | -1,468,706USD | -1,893,750USD | -1,837,866USD | -2,097,870USD | -4,039,603USD | — |
| Unclassified Non Current Liabilities | 1,600,747USD | — | — | — | 1,114,219USD | 1,437,286USD | — | — |
| Unclassified Equity | 87,432,514USD | 69,671,506USD | 65,068,772USD | 58,804,193USD | 48,984,741USD | 31,627,387USD | 14,997,550USD | 12,700,629USD |
| Current Deferred Revenue | — | 81,115USD | 79,500USD | 10,985USD | 10,985USD | 12,070USD | 13,085USD | — |
| Net Receivables | — | 1,155,051USD | 759,566USD | 1,369,487USD | 426,091USD | 999,402USD | 640,526USD | 14,639USD |
| Non Current Liabilities Other | — | 21,680USD | 21,680USD | 7,980USD | 10,580USD | 19,280USD | 2,880USD | — |
| Accounts Payable | — | — | 112,946USD | — | 0USD | 23,044USD | 23,995USD | 14,639USD |
| Inventory | — | — | — | 1,306,463USD | 25,975USD | -839,690USD | -476,960USD | 1,318USD |
| Unclassified Current Assets | — | — | — | -1,306,463USD | — | -1,190,727USD | -3,841,579USD | — |
| Unclassified Non Current Assets | — | — | — | 2,337,027USD | -1,142,378USD | 2,995,526USD | — | 4,836,164USD |
| Other Liab | — | — | — | — | 10,580USD | 19,280USD | 2,880USD | 27,467USD |
| Good Will | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Other Assets | — | — | — | — | 1,142,378USD | 1,955,431USD | 1,639,579USD | -5,373,648USD |
| Net Tangible Assets | — | — | — | — | 8,843,653USD | 3,438,340USD | -150,964USD | -5,657,996USD |
| Long Term Debt | — | — | — | — | — | 2,624,400USD | — | 250,000USD |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,689,937USD | -3,812,413USD | -1,246,513USD | -2,257,022USD | -944,190USD | 229,304USD | -186,561USD | -942,336USD |
| Depreciation | 92,156USD | 214,043USD | 96,011USD | 80,832USD | 113,948USD | 179,316USD | 7,014USD | 114,327USD |
| Stock Based Compensation | 787,374USD | 1,386,213USD | 1,136,217USD | 1,571,613USD | 48,773USD | -184,276USD | 643,230USD | 282,875USD |
| Other Non Cash Items | 32,584USD | 865,041USD | 21,837USD | 99,866USD | 260,917USD | -601,260USD | 338,657USD | 46,326USD |
| Change To Account Receivables | -208,887USD | 33,295USD | 264,529USD | -318,642USD | 54,113USD | 0USD | 140,364USD | -378,251USD |
| Change To Inventory | 0USD | 0USD | 0USD | 0USD | -11,460USD | — | 0USD | 0USD |
| Change In Working Capital | -116,420USD | -71,919USD | -140,809USD | -389,463USD | -19,281USD | -220,556USD | 12,614USD | 287,383USD |
| Total Cash From Operating Activities | -894,243USD | -1,419,035USD | -133,257USD | -894,174USD | -539,833USD | -493,611USD | 171,724USD | -211,425USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | -3USD | 0USD | -3USD | -3USD |
| Free Cash Flow | -894,243USD | -1,419,035USD | -133,257USD | -894,174USD | -539,833USD | -493,611USD | 171,724USD | -211,425USD |
| Investments | -680,000USD | — | -1,273,357USD | -665,779USD | 0USD | 0USD | 501,614USD | -501,614USD |
| Total Cashflows From Investing Activities | 47,123USD | 730,346USD | -1,273,357USD | -665,779USD | — | — | — | -501,614USD |
| Net Borrowings | -661,650USD | 549,881USD | -158,690USD | -20,615USD | -29,250USD | -87,044USD | -916,625USD | — |
| Total Cash From Financing Activities | -342,181USD | 1,149,517USD | 1,132,395USD | 1,927,327USD | 428,756USD | 581,456USD | -145,393USD | 802,156USD |
| Change In Cash | -1,186,661USD | 473,074USD | -222,415USD | 316,758USD | -104,247USD | 93,942USD | 27,104USD | 83,767USD |
| Begin Period Cash Flow | 1,326,985USD | 853,911USD | 1,076,326USD | 759,568USD | 863,815USD | 769,873USD | 742,769USD | 659,002USD |
| End Period Cash Flow | 140,324USD | 1,326,985USD | 853,911USD | 1,076,326USD | 759,568USD | 863,815USD | 769,873USD | 742,769USD |
| Other Cashflows From Investing Activities | 47,123USD | 730,346USD | -1,273,357USD | -665,779USD | — | — | 3USD | -501,614USD |
| Other Cashflows From Financing Activities | -102,023USD | 71,453USD | 982,395USD | 1,927,327USD | 46,339USD | — | -145,393USD | 802,156USD |
| Sale Purchase Of Stock | — | -7,670,000USD | 7,670,000USD | — | -7,320USD | — | — | — |
| Issuance Of Capital Stock | — | 528,183USD | 738,370USD | — | — | -133,732USD | 33,732USD | — |
| Unclassified Financing Cash Flow | — | 8,198,183USD | -7,361,310USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 1,273,357USD | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -8,376,959USD | -5,259,037USD | -7,788,050USD | -16,312,374USD | -12,035,851USD | -10,593,584USD | -3,933,240USD | -4,101,303USD |
| Depreciation | 504,834USD | 200,921USD | 380,390USD | 23,799USD | 11,993USD | 37,142USD | 55,086USD | 43,610USD |
| Stock Based Compensation | 4,142,816USD | 2,773,460USD | 185,933USD | 7,036,778USD | 5,306,755USD | 4,146,979USD | 22,314USD | 28,800USD |
| Other Non Cash Items | 1,358,312USD | 883,933USD | 2,725,569USD | 353,039USD | -91,054USD | 2,155,179USD | 204,339USD | 2,550,000USD |
| Change To Account Receivables | -136,501USD | -293,962USD | 228,557USD | -614,166USD | -120,980USD | 3,696USD | -120,739USD | 11,227USD |
| Change To Inventory | -11,460USD | 0USD | 68,515USD | 25,975USD | -25,830USD | -88,164USD | 1,306USD | 14,798USD |
| Change In Working Capital | -615,302USD | -408,422USD | 309,310USD | 635,565USD | -1,613,761USD | -86,434USD | 597,667USD | 892,308USD |
| Total Cash From Operating Activities | -2,986,299USD | -1,809,145USD | -4,186,848USD | -7,398,391USD | -7,597,719USD | -4,563,919USD | -3,134,526USD | -630,195USD |
| Capital Expenditures | -5,791USD | 0USD | -21,201USD | -119,692USD | -17,503USD | -17,503USD | -17,503USD | -17,503USD |
| Free Cash Flow | -2,986,299USD | -1,809,145USD | -4,208,049USD | -7,518,083USD | -7,615,222USD | -4,563,919USD | -3,134,526USD | -630,195USD |
| Total Cashflows From Investing Activities | -1,208,790USD | — | -360,186USD | -1,721,684USD | -805,966USD | -225,431USD | -35,297USD | -156,372USD |
| Net Borrowings | 341,326USD | 15,926USD | 462,622USD | 350,000USD | -273,473USD | 1,952,512USD | 2,003,380USD | 896,864USD |
| Total Cash From Financing Activities | 4,637,995USD | 1,980,769USD | 3,869,961USD | 4,013,925USD | 9,995,550USD | 9,567,843USD | 3,087,489USD | 593,000USD |
| Sale Purchase Of Stock | 0USD | -7,320USD | 0USD | — | — | — | — | 0USD |
| Issuance Of Capital Stock | 3,305,303USD | 31,040USD | 1,050,000USD | 3,663,925USD | 11,119,452USD | 7,615,331USD | 1,084,109USD | — |
| Change In Cash | 463,170USD | 147,035USD | -674,948USD | -5,173,487USD | 1,563,844USD | 4,840,928USD | -82,338USD | -37,195USD |
| Begin Period Cash Flow | 863,815USD | 716,780USD | 1,391,728USD | 6,565,215USD | 5,001,371USD | 160,443USD | 242,781USD | 93,332USD |
| End Period Cash Flow | 1,326,985USD | 863,815USD | 716,780USD | 1,391,728USD | 6,565,215USD | 5,001,371USD | 160,443USD | 56,137USD |
| Other Cashflows From Investing Activities | -1,208,790USD | — | -338,985USD | -1,601,992USD | -788,463USD | -373,235USD | 305USD | -156,372USD |
| Other Cashflows From Financing Activities | 4,637,995USD | 1,941,123USD | 2,593,838USD | -1,721,684USD | -533,071USD | -225,431USD | 552,962USD | 850,000USD |
| Investments | — | 0USD | -360,186USD | -1,721,684USD | -805,966USD | 147,804USD | -17,801USD | -156,372USD |
| Change To Liabilities | — | — | — | 0USD | -23,044USD | -951USD | 50,244USD | -98,350USD |
| Unclassified Investing Cash Flow | — | — | — | 1,721,684USD | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | 1,721,684USD | — | — | — | -1,153,864USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2024Quarterly · 2024-09-30 | Product | Licensing Revenues | 380,000 | USD | 0001213900-24-097840 |
| Q3 2024Quarterly · 2024-09-30 | Product | Other Revenues | 9,276 | USD | 0001213900-24-097840 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.